Medical Condition News

RSS

Research provides new understanding of how heroin affects the brain

New research from the Norwegian Institute of Public Health suggests that our understanding of how heroin affects the brain should be changed. A new report shows that heroin is metabolised to 6-MAM which then crosses the blood-brain barrier to cause the intoxicating effects that arise shortly after heroin administration.

27 May 2011

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.

27 May 2011

Insight into new prion formation

Unlocking the mechanisms that cause neurodegenerative prion diseases may require a genetic key, suggest new findings reported by University of Illinois at Chicago distinguished professor of biological sciences Susan Liebman.

27 May 2011

Leukemia, psoriasis drugs may treat vascular diseases

A drug that has been on the market for decades to treat leukemia and skin disorders such as acne and psoriasis may be a possible therapy for vascular diseases, including atherosclerosis and hypertension, which can lead to heart attack or stroke.

27 May 2011

Exposure to pesticides near any workplace increases risk of Parkinson's disease

In April 2009, researchers at UCLA announced they had discovered a link between Parkinson's disease and two chemicals commonly sprayed on crops to fight pests.

27 May 2011

Biosign to demonstrate latest generation medical measurement system at International MeMeA symposium

Biosign Technologies Inc. announced today that it will introduce its latest generation medical measurement system, the UFIT TEN-20, at the International Symposium on Medical Measurements and Applications, being held in Italy by the Institute of Electrical and Electronics Engineers on May 30-31, 2011. Dr Radu Leca, Biosign's CEO, will speak and demonstrate the system during the Plenary Session - Invited Lecture "Issues in Medical Measurement".

27 May 2011

ViroPharma launches documentary film on hereditary angioedema

ViroPharma Incorporated today announced the launch of the documentary Swell, a twenty-five minute film that allows families dealing with the rare genetic swelling disease, hereditary angioedema, to share the challenges and triumphs of living with a chronic disorder.

27 May 2011

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, in London, UK, from May 25-28, 2011.

27 May 2011

ARCA plans to expand development program for Gencaro in atrial fibrillation

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it is planning to expand the development of Gencaro, its lead cardiovascular drug candidate, to atrial fibrillation, a disease that affects more than 2.4 million patients in the United States.

27 May 2011

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

27 May 2011

Southern U.S. Stroke Belt population have greater incidence of cognitive decline

New research shows that residents of the Stroke Belt—a southern portion of the U.S. with significantly elevated stroke morality rate—also have a greater incidence of cognitive decline than other regions of the country.

27 May 2011

Researchers find mechanism of action for cancer-killing peptides

Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria.

27 May 2011

Tacrolimus prevents breast cancer growth in pre-clinical studies

Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE.

27 May 2011

Research sheds light on how painkillers could prevent or slow down cancer growth

CANCER RESEARCH UK scientists have shed light on how a common class of painkillers - which includes ibuprofen - may interact with a key protein that fuels the growth of many different types of cancer, according to a study published in the journal Chemical Communications today.

27 May 2011

New genomics research on abnormal brain development

Local researchers are finally on the road to developing targeted treatments for serious, life-long disabilities such as autism and schizophrenia, thanks to new genomics research focusing on abnormal brain development.

27 May 2011

Kaiser Permanente Downey Medical Center offers free life-changing procedures for uninsured patients

Patients from Family Health Care Centers of Greater Los Angeles received pro bono outpatient surgeries to repair hernias, remove cataracts and gallbladders on Saturday, May 21. A team of about 70 doctors, nurses and support staff from Kaiser Permanente Downey Medical Center worked for free to provide patients with life-changing procedures—some have been waiting for months even years for these surgeries.

27 May 2011

Omega-3 fatty acids reduce risk of heart attack in stent patients

Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

27 May 2011

DHF receives two Telly Awards for diabetes awareness video Big Blue Test

Diabetes Hands Foundation (DHF) announced today that it is the recipient of two Telly Awards for the diabetes awareness video Big Blue Test.

27 May 2011

Naturally occurring plant alkaloids could help prevent, delay memory loss linked with Alzheimer's

A family of naturally occurring plant compounds could help prevent or delay memory loss associated with Alzheimer's disease, according to a new study by the Translational Genomics Research Institute.

27 May 2011

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.

27 May 2011

Medical Condition News

Research provides new understanding of how heroin affects the brain

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

Insight into new prion formation

Leukemia, psoriasis drugs may treat vascular diseases

Exposure to pesticides near any workplace increases risk of Parkinson's disease

Biosign to demonstrate latest generation medical measurement system at International MeMeA symposium

ViroPharma launches documentary film on hereditary angioedema

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

ARCA plans to expand development program for Gencaro in atrial fibrillation

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Southern U.S. Stroke Belt population have greater incidence of cognitive decline

Researchers find mechanism of action for cancer-killing peptides

Tacrolimus prevents breast cancer growth in pre-clinical studies

Research sheds light on how painkillers could prevent or slow down cancer growth

New genomics research on abnormal brain development

Kaiser Permanente Downey Medical Center offers free life-changing procedures for uninsured patients

Omega-3 fatty acids reduce risk of heart attack in stent patients

DHF receives two Telly Awards for diabetes awareness video Big Blue Test

Naturally occurring plant alkaloids could help prevent, delay memory loss linked with Alzheimer's

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News